Rescuing the failing heart by targeted gene transfer

Journal of the American College of Cardiology

Volumn 57, Issue 10, 2011, Pages 1169-1180

  Kawase, Yoshiaki ^a   Ladage, Dennis ^a   Hajjar, Roger J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

calcium; gene therapy; heart failure; sarcoplasmic reticulum

Indexed keywords

ACRX 100; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOVIRUS VECTOR; ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; CALCIUM CHANNEL L TYPE; CALCIUM ION; G PROTEIN COUPLED RECEPTOR KINASE; GENE THERAPY AGENT; LENTIVIRUS VECTOR; LIPOPLEX; LIPOSOME; NUCLEASE; PARVOVIRUS VECTOR; PHOSPHOLAMBAN; PHOSPHOPROTEIN PHOSPHATASE 1; PLACEBO; PROTEIN S 100; RETROVIRUS VECTOR; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; VIRUS VECTOR; ZINC FINGER PROTEIN;

ADRENERGIC SYSTEM; ARTICLE; CALCIUM TRANSPORT; CATHETERIZATION; CELL DEATH; CELL HOMING; CONGESTIVE HEART FAILURE; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; DNA REPAIR; DNA SEQUENCE; DRUG DELIVERY SYSTEM; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; ENZYME INHIBITION; GENE TRANSFER; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE REPERFUSION; HUMAN; IMMUNE RESPONSE; MORBIDITY; MORTALITY; NONVIRAL GENE DELIVERY SYSTEM; PERICARDIUM; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SARCOPLASMIC RETICULUM; SINGLE DRUG DOSE;

EID: 79952299939     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.11.023     Document Type: Review

References (78)

1. P.L. Felgner Nonviral strategies for gene therapy Sci Am 276 1997 102 106
2. G.J. Nabel The future of gene therapy Ernst Schering Research Foundation Workshop 2003 1 16
3. J.J. Green, R. Langer, and D.G. Anderson A combinatorial polymer library approach yields insight into nonviral gene delivery Acc Chem Res 2008 May 29 [E-pub ahead of print]
4. R.J. Guzman, P. Lemarchand, R.G. Crystal, S.E. Epstein, and T. Finkel Efficient and selective adenovirus-mediated gene transfer into vascular neointima Circulation 88 1993 2838 2848 (Pubitemid 23360211)
5. U. Sambamoorthi, A. Akincigil, E. McSpiritt, and S. Crystal Zidovudine use during pregnancy among HIV-infected women on Medicaid J Acquir Immune Defic Syndr 30 2002 429 439 (Pubitemid 34857318)
6. R.J. Hajjar, U. Schmidt, and T. Matsui Modulation of ventricular function through gene transfer in vivo Proc Natl Acad Sci U S A 95 1998 5251 5256 (Pubitemid 28208584)
7. R. Beeri, J.L. Guerrero, G. Supple, S. Sullivan, R.A. Levine, and R.J. Hajjar New efficient catheter-based system for myocardial gene delivery Circulation 106 2002 1756 1759
8. P.E. Monahan, and R.J. Samulski AAV vectors: is clinical success on the horizon? Gene Ther 7 2000 24 30 (Pubitemid 30077145)
9. C.S. Manno, G.F. Pierce, and V.R. Arruda Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response Nat Med 12 2006 342 347 (Pubitemid 43355084)
10. P.J. Carter, and R.J. Samulski Adeno-associated viral vectors as gene delivery vehicles Int J Mol Med 6 2000 17 27
11. D.M. McCarty, P.E. Monahan, and R.J. Samulski Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis Gene Ther 8 2001 1248 1254 (Pubitemid 32780813)
12. J.E. Rabinowitz, D.E. Bowles, S.M. Faust, J.G. Ledford, S.E. Cunningham, and R.J. Samulski Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups J Virol 78 2004 4421 4432 (Pubitemid 38501062)
13. L. Yang, J. Jiang, and L.M. Drouin A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection Proc Natl Acad Sci U S A 106 2009 3946 3951
14. M. Cavazzana-Calvo, S. Hacein-Bey, and G. de Saint Basile Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease Science 288 2000 669 672 (Pubitemid 30241569)
15. N. Klages, R. Zufferey, and D. Trono A stable system for the high-titer production of multiply attenuated lentiviral vectors Mol Ther 2 2000 170 176
16. F. Galimi, M. Noll, and Y. Kanazawa Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors Blood 100 2002 2732 2736
17. S. Hacein-Bey-Abina, C. Von Kalle, and M. Schmidt LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 Science 302 2003 415 419 (Pubitemid 37296260)
18. F. Paques, and P. Duchateau Meganucleases and DNA double-strand break-induced recombination: perspectives for gene therapy Curr Gene Ther 7 2007 49 66 (Pubitemid 46322288)
19. A. Klug The discovery of zinc fingers and their applications in gene regulation and genome manipulation Annu Rev Biochem 79 2010 213 231
20. P. Chapdelaine, C. Pichavant, J. Rousseau, F. Paques, and J.P. Tremblay Meganucleases can restore the reading frame of a mutated dystrophin Gene Ther 17 2010 846 858
21. T. Konno, S. Chang, J.G. Seidman, and C.E. Seidman Genetics of hypertrophic cardiomyopathy Curr Opin Cardiol 2010 Jan 30 [E-pub ahead of print]
22. K. Nagata, E. Marban, J.H. Lawrence, and J.K. Donahue Phosphodiesterase inhibitor-mediated potentiation of adenovirus delivery to myocardium J Mol Cell Cardiol 33 2001 575 580 (Pubitemid 32539012)
23. N.C. Lai, D.M. Roth, and M.H. Gao Intracoronary adenovirus encoding adenylyl cyclase VI increases left ventricular function in heart failure Circulation 110 2004 330 336 (Pubitemid 38955502)
24. Y. Kawase, H.Q. Ly, and F. Prunier Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure J Am Coll Cardiol 51 2008 1112 1119 (Pubitemid 351374774)
25. M.J. Byrne, J.M. Power, A. Preovolos, J.A. Mariani, R.J. Hajjar, and D.M. Kaye Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals Gene Ther 15 2008 1550 1557
26. D.M. Kaye, A. Preovolos, and T. Marshall Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals J Am Coll Cardiol 50 2007 253 260 (Pubitemid 47031573)
27. P. Boekstegers, G. von Degenfeld, and W. Giehrl Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins Gene Ther 7 2000 232 240 (Pubitemid 30113772)
28. C. Kupatt, R. Hinkel, and M. Lamparter Retroinfusion of embryonic endothelial progenitor cells attenuates ischemia-reperfusion injury in pigs: role of phosphatidylinositol 3-kinase/AKT kinase Circulation 112 2005 I117 I122
29. C. Kupatt, R. Wichels, and M. Deiss Retroinfusion of NFkappaB decoy oligonucleotide extends cardioprotection achieved by CD18 inhibition in a preclinical study of myocardial ischemia and retroinfusion in pigs Gene Ther 9 2002 518 526 (Pubitemid 34449772)
30. K. Hoshino, T. Kimura, and A.M. De Grand Three catheter-based strategies for cardiac delivery of therapeutic gelatin microspheres Gene Ther 13 2006 1320 1327 (Pubitemid 44323688)
31. C.A. Thompson, B.A. Nasseri, and J. Makower Percutaneous transvenous cellular cardiomyoplasty A novel nonsurgical approach for myocardial cell transplantation J Am Coll Cardiol 41 2003 1964 1971 (Pubitemid 36677117)
32. H.C. Champion, D. Georgakopoulos, S. Haldar, L. Wang, Y. Wang, and D.A. Kass Robust adenoviral and adeno-associated viral gene transfer to the in vivo murine heart: application to study of phospholamban physiology Circulation 108 2003 2790 2797 (Pubitemid 37498982)
33. M. Iwatate, Y. Gu, and T. Dieterle In vivo high-efficiency transcoronary gene delivery and Cre-LoxP gene switching in the adult mouse heart Gene Ther 10 2003 1814 1820 (Pubitemid 37185139)
34. M.J. Davidson, J.M. Jones, and S.M. Emani Cardiac gene delivery with cardiopulmonary bypass Circulation 104 2001 131 133 (Pubitemid 32655825)
35. C.R. Bridges 'Recirculating cardiac delivery' method of gene delivery should be called 'non-recirculating' method Gene Ther 16 2009 939 940
36. C.R. Bridges, K. Gopal, and D.E. Holt Efficient myocyte gene delivery with complete cardiac surgical isolation in situ J Thorac Cardiovasc Surg 130 2005 1364
37. S. Engelhardt, L. Hein, V. Dyachenkow, E.G. Kranias, G. Isenberg, and M.J. Lohse Altered calcium handling is critically involved in the cardiotoxic effects of chronic beta-adrenergic stimulation Circulation 109 2004 1154 1160 (Pubitemid 38332620)
38. C.A. Milano, L.F. Allen, and H.A. Rockman Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor Science 264 1994 582 586
39. J.P. Maurice, J.A. Hata, and A.S. Shah Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery J Clin Invest 104 1999 21 29 (Pubitemid 29534341)
40. A.S. Shah, R.E. Lilly, and A.P. Kypson Intracoronary adenovirus-mediated delivery and overexpression of the beta(2)-adrenergic receptor in the heart: prospects for molecular ventricular assistance Circulation 101 2000 408 414 (Pubitemid 30067398)
41. J.A. Hata, M.L. Williams, and W.J. Koch Genetic manipulation of myocardial beta-adrenergic receptor activation and desensitization J Mol Cell Cardiol 37 2004 11 21 (Pubitemid 38900524)
42. P.W. Raake, L.E. Vinge, and E. Gao G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure Circ Res 103 2008 413 422
43. A.S. Shah, D.C. White, and S. Emani In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction Circulation 103 2001 1311 1316 (Pubitemid 32221357)
44. M.H. Gao, N.C. Lai, and D.M. Roth Adenylylcyclase increases responsiveness to catecholamine stimulation in transgenic mice Circulation 99 1999 1618 1622 (Pubitemid 29152931)
45. N.C. Lai, D.M. Roth, and M.H. Gao Intracoronary delivery of adenovirus encoding adenylyl cyclase VI increases left ventricular function and cAMP-generating capacity Circulation 102 2000 2396 2401
46. P. Nicolaou, P. Rodriguez, and X. Ren Inducible expression of active protein phosphatase-1 inhibitor-1 enhances basal cardiac function and protects against ischemia/reperfusion injury Circ Res 104 2009 1012 1020
47. A. Pathak, B. Baldwin, and E.G. Kranias Key protein alterations associated with hyperdynamic cardiac function: insights based on proteomic analysis of the protein phosphatase 1 inhibitor-1 overexpressing hearts Hellenic J Cardiol 48 2007 30 36 (Pubitemid 47621109)
48. A. Pathak, F. del Monte, and W. Zhao Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1 Circ Res 96 2005 756 766 (Pubitemid 40559515)
49. J.K. Gwathmey, L. Copelas, and R. MacKinnon Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure Circ Res 61 1987 70 76 (Pubitemid 17133480)
50. G. Hasenfuss, H. Reinecke, and R. Studer Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium Circ Res 75 1994 434 442
51. M. Meyer, W. Schillinger, and B. Pieske Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy Circulation 92 1995 778 784
52. U. Schmidt, R.J. Hajjar, C.S. Kim, D. Lebeche, A.A. Doye, and J.K. Gwathmey Human heart failure: cAMP stimulation of SR Ca(2+)-ATPase activity and phosphorylation level of phospholamban Am J Physiol 277 1999 H474 H480
53. A.M. Lompre, F. Lambert, E.G. Lakatta, and K. Schwartz Expression of sarcoplasmic reticulum Ca(2+)-ATPase and calsequestrin genes in rat heart during ontogenic development and aging Circ Res 69 1991 1380 1388
54. M.I. Miyamoto, F. del Monte, and U. Schmidt Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure Proc Natl Acad Sci U S A 97 2000 793 798 (Pubitemid 30070389)
55. F. del Monte, S.E. Harding, and U. Schmidt Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a Circulation 100 1999 2308 2311
56. L. Hadri, R. Bobe, and Y. Kawase SERCA2a gene transfer enhances eNOS expression and activity in endothelial cells Mol Ther 18 2010 1284 1292
57. F. del Monte, E. Williams, and D. Lebeche Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure Circulation 104 2001 1424 1429 (Pubitemid 32880157)
58. F. Prunier, Y. Kawase, and D. Gianni Prevention of ventricular arrhythmias with sarcoplasmic reticulum Ca2+ ATPase pump overexpression in a porcine model of ischemia reperfusion Circulation 118 2008 614 624
59. S. Sakata, D. Lebeche, and N. Sakata Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins J Mol Cell Cardiol 42 2007 852 861 (Pubitemid 46527593)
60. F. del Monte, S.E. Harding, G.W. Dec, J.K. Gwathmey, and R.J. Hajjar Targeting phospholamban by gene transfer in human heart failure Circulation 105 2002 904 907 (Pubitemid 34184564)
61. L. Suckau, H. Fechner, and E. Chemaly Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy Circulation 119 2009 1241 1252
62. P. Most, S.T. Pleger, and M. Vlkers Cardiac adenoviral S100A1 gene delivery rescues failing myocardium J Clin Invest 114 2004 1550 1563 (Pubitemid 40385546)
63. S.T. Pleger, P. Most, and M. Boucher Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue Circulation 115 2007 2506 2515 (Pubitemid 46763224)
64. P. Most, and W.J. Koch S100A1: a calcium-modulating inotropic prototype for future clinical heart failure therapy Future Cardiol 3 2007 5 11 (Pubitemid 46157665)
65. U. Agarwal, W. Ghalayini, and F. Dong Role of cardiac myocyte CXCR4 expression in development and left ventricular remodeling after acute myocardial infarction Circ Res 107 2010 667 676
66. R. Calcedo, L.H. Vandenberghe, G. Gao, J. Lin, and J.M. Wilson Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses J Infect Dis 199 2009 381 390
67. S. Boutin, V. Monteilhet, and P. Veron Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors Hum Gene Ther 21 2010 704 712
68. F. Mingozzi, J.J. Meulenberg, and D.J. Hui AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells Blood 114 2009 2077 2086
69. F. Mingozzi, M.V. Maus, and D.J. Hui CD8(+) T-cell responses to adeno-associated virus capsid in humans Nat Med 13 2007 419 422 (Pubitemid 46559826)
70. J.M. Wilson Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency Mol Genet Metab 96 2009 151 157
71. S.E. Raper, N. Chirmule, and F.S. Lee Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer Mol Genet Metab 80 2003 148 158 (Pubitemid 37272241)
72. S.E. Raper, M. Yudkoff, and N. Chirmule A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency Hum Gene Ther 13 2002 163 175 (Pubitemid 34075180)
73. S. Hacein-Bey-Abina, J. Hauer, and A. Lim Efficacy of gene therapy for X-linked severe combined immunodeficiency N Engl J Med 363 2010 355 364
74. B. Neven, S. Leroy, and H. Decaluwe Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency Blood 113 2009 4114 4124
75. D. Moshous, C. Pannetier, and R. Chasseval Rd Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis J Clin Invest 111 2003 381 387 (Pubitemid 36182215)
76. J.W. Bainbridge, A.J. Smith, and S.S. Barker Effect of gene therapy on visual function in Leber's congenital amaurosis N Engl J Med 358 2008 2231 2239 (Pubitemid 351724452)
77. R.J. Hajjar, K. Zsebo, and L. Deckelbaum Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure J Card Fail 14 2008 355 367 (Pubitemid 351756538)
78. B.E. Jaski, M.L. Jessup, and D.M. Mancini Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial J Card Fail 15 2009 171 181